Immuron (IMRN) Share-based Compensation (2020 - 2021)
Immuron (IMRN) posted quarterly Share-based Compensation of $1.6 million for Q2 2021, up 565.64% year-over-year from $244794.0 in Q2 2020, and up 565.64% quarter-over-quarter from -$349936.9 in Q2 2020.
Immuron (IMRN) Share-based Compensation (2020 - 2021) Analysis & Trends
Immuron's Share-based Compensation history runs 2 years deep, the most recent figure standing at $1.6 million for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1.63 Mn |
| Jun 30, 2020 | -349,936.94 |
| Jun 30, 2020 | -349,936.94 |